Redcare Pharmacy NV Cash Flow Conversion Efficiency

Latest as of December 2025: -0.039x

Redcare Pharmacy NV cash flow conversion efficiency. Based on the latest financial reports, Redcare Pharmacy NV (RDC) has a cash flow conversion efficiency ratio of -0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.82 Million ≈ $-22.00 Million USD) by net assets (€479.20 Million ≈ $560.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Redcare Pharmacy NV (2019–2025)

Cash flow conversion efficiency of Redcare Pharmacy NV from 2019 to 2025. This chart illustrates how Redcare Pharmacy NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RDC stock price and chart for real-time trading data and today's change.

Redcare Pharmacy NV Cash Flow Conversion Ratio Explained

Redcare Pharmacy NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Redcare Pharmacy NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Redcare Pharmacy NV ranked by their cash flow conversion efficiency. Also see Redcare Pharmacy NV market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Beijing Sanyuan Foods Co Ltd SHG:600429	0.037x
Guizhou Gas Group Corporation Ltd Class A SHG:600903	-0.004x
ZEAL Network SE XETRA:TIMA	0.163x
Top Energy Shanxi Co Ltd SHG:600780	0.054x
ODDITY Tech Ltd. Class A Ordinary Shares NASDAQ:ODD	-0.023x
Zhejiang Sanwei Rubber Item Co SHG:603033	0.002x
Compass Minerals International Inc NYSE:CMP	0.618x
Yulon Motor Co Ltd TW:2201	-0.013x

Annual Cash Flow Conversion Efficiency for Redcare Pharmacy NV (2019–2025)

The table below shows the annual cash flow conversion efficiency of Redcare Pharmacy NV from 2019 to 2025. Review RDC free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€479.20 Million ≈ $560.24 Million	€31.00 Million ≈ $36.24 Million	0.065x	+49.28%
2024-12-31	€509.97 Million ≈ $596.21 Million	€22.10 Million ≈ $25.84 Million	0.043x	-61.07%
2023-12-31	€552.03 Million ≈ $645.38 Million	€61.46 Million ≈ $71.85 Million	0.111x	+235.61%
2022-12-31	€354.63 Million ≈ $414.60 Million	€-29.11 Million ≈ $-34.03 Million	-0.082x	-393.10%
2021-12-31	€415.41 Million ≈ $485.66 Million	€11.63 Million ≈ $13.60 Million	0.028x	-33.11%
2020-12-31	€425.14 Million ≈ $497.03 Million	€17.80 Million ≈ $20.81 Million	0.042x	+131.72%
2019-12-31	€232.76 Million ≈ $272.12 Million	€-30.73 Million ≈ $-35.92 Million	-0.132x	--

About Redcare Pharmacy NV

F:RDC Germany Pharmaceutical Retailers

Market Cap

$1.76 Billion

€1.51 Billion EUR

Market Cap Rank

#8721 Global

#1146 in Germany

Share Price

€74.10

Change (1 day)

+6.62%

52-Week Range

€30.82 - €78.65

All Time High

€246.00